Exp Clin Endocrinol Diabetes 2002; 110(1): 22-26
DOI: 10.1055/s-2002-19990
Articles

© Johann Ambrosius Barth

Pathogenesis of diabetic neuropathy - do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?

A. Colciago 1 , P. Negri-Cesi 1 , F. Celotti 1
  • 1 Department of Endocrinology, University of Milano, Italy
Further Information

Publication History

received 13 March 2001 first decision 29 June 2001

received 30 August 2001

Publication Date:
07 February 2002 (online)

Preview

Summary

The activation of the polyol pathway through aldose reductase (AR) might be involved in diabetic neuropathy. A considerable structural similarity exists between AR and 3α-hydroxysteroid dehydrogenase (3α-HSD) (both belonging to aldo-keto reductase superfamily); 3α-HSD forms 5α-reduced-3α-hydroxylated steroids, possibly possessing neurotrophic functions. Aim of these experiments was to test “in vitro” in rat sciatic nerves, whether glucose concentrations in the diabetic range might affect the capacity of 3α-HSD to transform dihydroprogesterone (DHP) into tetrahydroprogesterone (THP), a steroid proved to possess neurotrophic effects. The capability of AR inhibitors, drugs used to avoid diabetic complications, to decrease THP formation was also assessed.

3α-HSD activity was evaluated by the conversion of labelled DHP into THP (in a single case dihydrotestosterone was used as substrate, and the corresponding 3α-hydroxylated metabolite was evaluated). Freshly prepared rat sciatic nerve homogenates were used as source of the enzyme. Whole brain, liver and prostate served as “control” tissues.

The results show that glucose added up to a concentration of 400 mg/dL (well above the euglycemic upper level) does not affect the 3α-HSD activity in the sciatic nerve and in the other tissues considered. Similarly, when the enzyme was challenged by two AR inhibitors, tolrestat and sorbinil, added in a concentration about 10 times higher than their IC50 for AR, no significant changes were observed. Analogous results were achieved when DHT was used in presence of glucose (400 mg/dL) and sorbinil. We conclude that hyperglycemia or the administration of the AR inhibitors do not affect 3α-HSD activity in peripheral nerves and therefore do not reduce the formation of steroid metabolites possibly endowed with neurotrophic action.

References

Fabio Celotti

Department of Endocrinology

University of Milano

Via Balzaretti 9

20135 Milano

Italy

Phone: +3902503-8208

Fax: +3902503-8204

Email: fabio.celotti@unimi.it